Adipocyte Gata3 Is a Diet-Inducible Driver of Pathological Adipose Remodeling and Systemic Metabolic Disease
Cells · 2026
DOI: 10.3390/cells15181644 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Minghui Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA. Hauptthemen laut MEDLINE: GATA3 Transcription Factor, Adipocytes, Adipose Tissue, Metabolic Diseases. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart Lung and Blood Institute, National Institutes of Health.
Abstract (Originalsprache)
Adipose tissue dysfunction drives obesity-associated metabolic disease, yet the transcriptional regulators of pathological adipose remodeling remain undefined. Here, we identify adipocyte Gata3 as a diet-inducible regulator that is dispensable for basal adipogenesis but necessary and sufficient for diet-induced obesity and systemic metabolic dysfunction. Adipocyte-specific Gata3 deletion redirects adipose expansion from hypertrophic to hyperplastic growth and improves glucose tolerance, insulin sensitivity, and adipose inflammation, whereas human GATA3 re-expression in adipocytes restores obesity and metabolic dysfunction, suggesting cross-species conservation and establishing both necessity and sufficiency for a causal driver. Multi-omic profiling, integrating proteomics, metabolomics, and single-cell mass cytometry, reveals that Gata3 loss suppresses a STAT3-anchored inflammatory myeloid program while enhancing mitochondrial oxidative capacity. Through further tracing of this adipocyte-intrinsic program to distal metabolic organs, systemic lipidomic and chemokine profiling identifies a two-pronged mechanism through which adipocyte Gata3 drives hepatic dysfunction: selective remodeling of lipoprotein-surface lipids and a coordinated CXCL5/CXCL2/CXCL9 chemokine axis. Collectively, these findings reposition Gata3 from a putative anti-adipogenic brake to a diet-inducible master regulator of pathological adipose remodeling and nominate adipocyte-targeted Gata3 inhibition as a strategy to uncouple adipose expansion from systemic metabolic disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Oppenheimer Atherosclerosis Research Center, Cedars Sinai Heart Institute Cedars-Sinai Med. Ctr., Los Angeles, CA 90048, USA.
- Smidt Heart Institute and Department of Cardiology, Cedar-Sinai Medical Center, Los Angeles, CA 90048, USA.
ORCID-Profile: Behrooz G Sharifi
Förderung
- NHLBI NIH HHS
- National Heart Lung and Blood Institute
- National Institutes of Health
- The Heart Foundation
Zitieren
APA
Qin, M., Li, F., Yang, M., Wang, L., Sharifi, B. G., & Shah, P. K. (2026). Adipocyte Gata3 Is a Diet-Inducible Driver of Pathological Adipose Remodeling and Systemic Metabolic Disease. Cells. https://doi.org/10.3390/cells15181644
Vancouver
Qin M, Li F, Yang M, Wang L, Sharifi BG, Shah PK. Adipocyte Gata3 Is a Diet-Inducible Driver of Pathological Adipose Remodeling and Systemic Metabolic Disease. Cells. 2026. doi:10.3390/cells15181644
BibTeX
@article{Qin2026,
author = {Qin, Minghui and Li, Fuqiang and Yang, Mingjie and Wang, Lai and Sharifi, Behrooz G and Shah, Prediman K},
title = {Adipocyte Gata3 Is a Diet-Inducible Driver of Pathological Adipose Remodeling and Systemic Metabolic Disease},
journal = {Cells},
year = {2026},
doi = {10.3390/cells15181644}
}
EUVIMED